Brief: Helix Biopharma names Gary Littlejohn interim CEO
29/10/2015 20:57
Oct 29 (Reuters) - Helix Biopharma Corp HBP.TO : * Announces fiscal 2015 results * Says appointment of Gary Littlejohn as interim chief executive officer as of November 1, 2015 * Source text for Eikon urn:newsml:reuters.com:*:nCCN8pGYYp * Further company coverage HBP.TO ((Bengaluru Newsroom; +1 646 223 8780))
Recent news on Helix Biopharma
See all newsBrief: Helix Biopharma Reports Q3 Loss Per Share C$0.02
Brief: Helix Biopharma Intends To File Interim Consolidated Financial Statements By July 30
Brief: Helix Biopharma To Divest Remaining Ownership Of Polish Subsidiary
Brief: Helix Biopharma Says Expects To File Interim Disclosure Documents By July 30, 2020
Brief: Helix Biopharma Says L-Dos47 Phase I Lung Cancer Trial Data To Be Released At Asco 2020